This Week on NeurologyLive

October 12, 2020

Here's what is coming soon to NeurologyLive.

Every week, the NeurologyLive staff prepares this preview of what to expect from our coverage. This week on NeurologyLive, there are a number of hot topics that we will be posting throughout the week.

Be on the lookout for an interview with Virendra Mishra, PhD, associate staff, Cleveland Clinic Lou Ruvo Center for Brain Health. Mishra stopped by to discuss a recent grant awarded to him by the National Institutes of Health (NIH) to identify biomarkers that predict dementia in patients with Parkinson disease (PD). He also provides insight into his plans to develop a method that can be applied in clinical care with a greater-than-chance success rate to improve patient outcomes.

To check out our conversations with his colleagues at Cleveland Clinic, click here.

Our Peer Exchange series, "Advances in the Management of Acute Treatment of Migraine," continues to premiere new episodes featuring insight from experts Peter J. Goadsby, MD, PhD; Dawn C. Buse, PhD; Wade M. Cooper, DO; Paul G. Mathew, MD; and Jelena Pavlovic, MD, PhD. In this set of episodes, the group offers comments on the use of 5-HT1F agonists, intranasal dihydroergotamine (DHE), and patient selection for novel therapies.

To check out the series, click here.

A conversation with Ana Pereira, MD, professor of neurology and neuroscience, Mount Sinai Hospital, about the findings of a randomized pilot trial of riluzole in patients with Alzheimer disease will publish in parts this week. Pereira presented her findings at the Alzheimer's Drug Discovery Foundation (ADDF) International Conference last week and discussed the data further on NeurologyLive.

To check out our latest coverage of Alzheimer disease, click here.

In partnership with the Consortium of Multiple Sclerosis Centers (CMSC) and the International Organization for Multiple Sclerosis Nurses (IOMSN), the second of 2 upcoming webcast programs on multiple sclerosis (MS) taking place in October, "Cannabis and MS: Helping Patients Understand Risks and Benefits," will air its first of 3 parts this Wednesday, October 14, at 7PM EDT (the following sessions will air on the 21st and 28th). This progressive webcast series features Allen C. Bowling, MD, PhD, director of the NeuroHealth Institute and clinical professor of neurology at the University of Colorado. Participants will earn 1 CE credit for completing each session.

To register for the webinar, click here.